14-day Premium Trial Subscription Sign Up For FreeGet Free

Aerie Pharmaceuticals Stock Forecast NASDAQ:AERI

Price Target and Analyst Ratings

Most Recent Rating

On September 16, 2021 "HC Wainwright" gave "$29.00" rating for AERI. The price target was changed from $11.96 to 23.8%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-16 $29.00 Reiterated by HC Wainwright $12.34 $11.96→23.8%
2021-09-10 $24.00 Initiated by Needham & Company LLC $16.63 $16.63+0.0%
2021-08-27 $24.00 Initiated by Needham & Company LLC $14.68 $14.68+0.0%
2021-08-05 $26.00 - $24.00 Target Lowered by Needham & Company LLC $15.01 $15.00→1.6%
2021-07-23 $26.00 Initiated by Needham & Company LLC $15.51 $15.510.0%
2021-07-22 $28.00 Reiterated by Mizuho $15.53 $16.19+2.9%
2021-07-16 $26.00 Initiated by Needham & Company LLC $15.27 $15.270.0%
2021-07-13 $15.65 Target Set by Raymond James $15.62 $15.65→0.9%
2021-07-12 Reiterated by Raymond James $15.65 $15.65→0.9%
2021-07-09 $26.00 Initiated by Needham & Company LLC $15.79 $15.79+3.1%
2021-07-02 Buy Initiated by Needham & Company LLC $16.01 $26.00
2021-04-30 Buy Initiated by Needham & Company LLC $17.13 $26.00
2021-04-23 Buy Initiated by Needham & Company LLC $17.65 $26.00
2021-03-01 Buy Reiterated by HC Wainwright $19.18
2021-02-05 Buy Initiated by Needham & Company LLC $17.68 $26.00
2020-12-28 Buy Reiterated by Mizuho $14.06 $28.00
2020-12-28 Buy Reiterated by Needham & Company LLC $14.06 $26.00
2020-11-09 Buy Target Lowered by HC Wainwright $12.38 $31.00 → $29.00
2020-11-06 Buy Reiterated by Mizuho $10.56
2020-10-19 Neutral - Underperform Downgraded by BofA Securities $9.92 $14.00 → $9.00
2020-10-19 Neutral - Underperform Downgraded by Bank of America $9.92 $14.00 → $9.00
2020-10-19 Neutral - Underperform Downgraded by Bank of America $9.92 $9.00
2020-10-19 Neutral - Underperform Downgraded by Bank of America $9.92
2020-10-05 Hold Reiterated by Raymond James $12.25
2020-10-05 Buy Reiterated by Needham & Company LLC $12.25 $26.00
2020-09-28 Hold Reiterated by Raymond James $11.03
2020-09-08 Buy Initiated by Guggenheim $11.95 $20.00
2020-09-08 Hold Reiterated by Raymond James $11.95
2020-08-24 Hold Reiterated by Raymond James $11.04
2020-08-10 Buy Target Lowered by Citigroup $12.89 $38.00 → $32.00
2020-08-07 Buy Target Raised by Mizuho $12.61 $27.00 → $29.00
2020-08-07 Buy Target Lowered by Needham & Company LLC $12.61 $32.00 → $26.00
2020-08-07 Target Lowered by Piper Sandler $12.61 $35.00 → $25.00
2020-07-28 Buy Reiterated by Mizuho $12.33 $29.00
2020-07-24 Buy Initiated by Needham & Company LLC $12.18 $32.00
2020-07-06 Buy Initiated by Needham & Company LLC $13.95 $38.00
2020-06-26 Buy Initiated by Needham & Company LLC $14.88 $38.00
2020-06-19 Buy Initiated by Needham & Company LLC $15.60 $38.00
2020-05-07 Buy Target Lowered by SunTrust Banks $14.45 $26.00 → $22.00
2020-05-07 Buy Target Lowered by Mizuho $14.45 $34.00 → $29.00
2020-05-07 Buy Target Lowered by HC Wainwright $14.45 $37.00 → $31.00
2020-05-07 Overweight Target Lowered by Piper Sandler $14.45 $45.00 → $35.00
2020-05-07 Buy Reiterated by Needham & Company LLC $14.45
2020-04-30 Buy Target Lowered by Needham & Company LLC $15.24 $40.00 → $38.00
2020-04-24 Buy Reiterated by Needham & Company LLC $14.30 $40.00
2020-04-13 Buy Target Lowered by Mizuho $15.11 $54.00 → $34.00
2020-04-13 Outperform Target Lowered by Oppenheimer $15.11 $28.00 → $26.00
2020-04-13 Buy Reiterated by Needham & Company LLC $15.11 $40.00

AERI Stock Trend

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($13.01) are considered to be a "second chance" to get out. According to the fan-theory $9.50 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Data

Date Bottom Mid Top
2021-09-20 $12.97 $14.73 $16.48
2021-09-21 $12.93 $14.69 $16.44
2021-09-22 $12.89 $14.65 $16.40
2021-09-23 $12.85 $14.61 $16.36
2021-09-24 $12.81 $14.57 $16.32
2021-09-27 $12.77 $14.53 $16.28
2021-09-28 $12.73 $14.49 $16.24
2021-09-29 $12.69 $14.45 $16.20
2021-09-30 $12.65 $14.41 $16.16
2021-10-01 $12.61 $14.37 $16.12
2021-10-04 $12.57 $14.33 $16.08
2021-10-05 $12.53 $14.29 $16.04
2021-10-06 $12.49 $14.25 $16.00
2021-10-07 $12.45 $14.21 $15.96
2021-10-08 $12.41 $14.17 $15.92
2021-10-11 $12.37 $14.13 $15.88
2021-10-12 $12.33 $14.09 $15.84
2021-10-13 $12.29 $14.05 $15.80
2021-10-14 $12.25 $14.01 $15.76
2021-10-15 $12.21 $13.97 $15.72
2021-10-18 $12.17 $13.93 $15.68
2021-10-19 $12.13 $13.89 $15.64
2021-10-20 $12.09 $13.85 $15.60
2021-10-21 $12.05 $13.81 $15.56
2021-10-22 $12.01 $13.77 $15.52
2021-10-25 $11.97 $13.73 $15.48
2021-10-26 $11.93 $13.69 $15.44
2021-10-27 $11.89 $13.65 $15.40
2021-10-28 $11.85 $13.61 $15.36
2021-10-29 $11.81 $13.57 $15.32

About Aerie Pharmaceuticals

Aerie Pharmaceuticals Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its product candidates include Rhopressa, a once-daily eye drop, which has completed Phase III registration trials for the reduction of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension; and Roclatan, a once-dai... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT